Hematopoiesis

Advances in Experimental Medicine and Biology

Volumn 567, Issue , 2005, Pages 167-185

  Savino, Wilson ^a,b   Smaniotto, Salete ^a,b,c   Dardenne, Mireille ^b  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b CNRS   (France)

^c FEDERAL UNIVERSITY OF ALAGOAS   (Brazil)

Author keywords

Apoptosis; Bone marrow; Chemokines; Cytokines; Extracellular matrix; Growth hormone; Hematopoiesis; Insulin like growth factors; Integrins; Thymic epithelial cells; Thymic nurse cells; Thymocytes; Thymulin; Thymus

Indexed keywords

CONCANAVALIN A; GROWTH HORMONE; SOMATOMEDIN C; THYMULIN; SOMATOMEDIN;

BONE MARROW; CELL DIFFERENTIATION; CELL INTERACTION; DRUG EFFECT; DRUG POTENTIATION; FLOW CYTOMETRY; GENETIC ENGINEERING; HEMATOPOIESIS; HEMATOPOIETIC CELL; HUMAN; LARON SYNDROME; MICROENVIRONMENT; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; PROTEIN PROCESSING; REVIEW; THYMOCYTE; ANIMAL; PHYSIOLOGY;

ANIMALS; GROWTH HORMONE; HEMATOPOIESIS; HUMANS; SOMATOMEDINS;

EID: 33644807663     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/0-387-26274-1_7     Document Type: Review

References (71)

1. H.D. Venters, R. Dantzer, G.G. Freund, S.R. Broussard and K.K. Kelley, Growth hormone and insulin-like growth factor as cytokines in the immune system. In. Psychoneuroimmunology, R. Ader, D.L. Felten and N. Cohen, Eds., 3rd Ed. Academic Press, San Diego, pp. 339-62 (2001).
2. W. Zumkeller, The insulin-like growth factor system in hematopoietic cells. Leukemia & Lymphoma, 43: 487-491 (2002).
3. M. Metcalf, Regulatory mechanisms controlling hematopoiesis: principles and problems. Stem cells, 16 Suppl 1: 3-11 (1998).
4. T. Lapidot and I. Petit, Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp Hematol, 30, 973-981 (2002).
5. F. Prosper and C.M. Verfaillie, Regulation of hematopoiesis through adhesion receptors. J Leukocyte Biol, 69, 307-316 (2001).
6. G. Anderson and E.J. Jenkinson, Lymphostromal interactions in thymic development and function. Nat Rev Immunol, 1, 31-40 (2001).
7. W. Savino and M. Dardenne, Neuroendocrine control of the thymus. Endocrine Rev, 21, 412-443 (2000).
8. W. Savino, D.A. Mendes-da-Cruz, J.S. Silva, M.Dardenne and V. Cotta-de-Almeida, Intrathymic T cell migration: a combinatorial interplay of extracellular matrix and chemokines? Trends Immunol, 23, 305-313 (2002).
9. W. Savino, S.R. Dalmau and V. Cotta-de-Almeida, Role of extracellular matrix mediated interactions in thymocyte migration. Dev Immunol, 7, 19-28 (2000).
10. F. Annunziato, P. Romagnani, L. Cosmi, E. Lazzeri and S. Romagnani, Chemokines and lymphopoiesis in the thymus. Trends Immunol, 22, 277-281 (2001).
11. K.M. Ansel and J.G. Cyster, Chemokines in lymphopoiesisand lymphoid organ development. Curr Opin Immunol, 13, 172-179 (2001).
12. S. Ben-Efraim, Y. Keisari, R. Ophir, M. Pecht, N Trainin and L. Burstein, Immunopotentiating and immunotherapeutic effects of thymic hormones and factors with special emphasis on thymic humoral factor THF-γ2. Crit Rev Immunol, 19, 261-284 (1999).
13. Y.H. Tseng, M.A. Kessler and L.A. Schuler, Regulation of interleukin (IL)-1α, IL-1β and IL-6 expression by growth hormone and prolactin in bovine thymic stromal cells, Mol Cell Endocrinol, 128, 117-127 (1997).
14. R.G. Goya, M.C. Gagnerault, M.C Leite-de-Moraes, W. Savino and M. Dardenne, In vivo effects of growth hormone on thymus function in aging mice. Brain Behav Immun, 6, 341-354 (1992).
15. - emigrants to peripheral lymphoid organs. Neuroimmunomodulation, 11, 299-306 (2004).
16. M. Pelletier, S. Montplaisir, M. Dardenne and J.F. Bach, Thymic hormone activity and spontaneous autoimmunity in dwarf mice and their littermates. Immunology, 30, 783-788 (1976).
17. E. Mocchegiani, P. Paolucci, A. Balsamo, E. Cacciari and N. Fabris, Influence of growth hormone on thymic endocrine activity in humans. Horm Res, 33, 248-255 (1990).
18. E. Mocchegiani, A. Sartorio, L. Santarelli, S. Ferrero and N. Fabris, Thymulin, zinc and insulin-like growth factor-I (IGF-1) activity before and during recombinant growth hormone (rec-GH) therapy in children and adults with GH deficiency. J Endocrinol Invest, 19, 630-637 (1996).
19. J. Timsit, B. Safieh, M.C. Gagnerault, W. Savino, J. Lubetzki, J.F. Bach and M. Dardenne, Increase of circulating levels of thymulin in hyperprolactinemia and acromegaly. C R. Acad Sci (Paris) Serie III, 310, 7-13 (1991).
20. S. Halvorsen and A.G. Bechensteen, Physiology of erythropoietin during mammalian development. Acta Paediatr, 91 Suppl, 17-26 (2002).
21. S.H. Boyer, T.R. Bisho, O.C. Rogers, A.N. Noyes, L.P. Frelin and S. Hobbs, Roles of erythropoietin, insulin-like growth factor 1, and unidentified serum factors in promoting maturation of purified murine erythroid colony-forming units. Blood, 80, 2503-2512 (1992).
22. S. Merchav, I. Silvian-Drachsler, I. Tatarsky, M. Lake and A. Skottner, Comparative studies of the erythroid-potentiating effects of biosynthetic human insulin-like growth factor-I and -II. J Clin Endocrinol Metabol, 74, 447-452 (1992).
23. S. Miyagawa, M. Kobayashi, N. Konishi, T. Sato, and K. Ueda, Insulin and insulin-like growth factor I support the proliferation of erythroid progenitor cells in bone marrow through the sharing of receptors. Brit J Hematol, 109, 555-562 (2000).
24. N. Hizuka, K. Takano, I. Tanaka, N. Honda, T. Tsushima and K. Shizume, Characterization of insulin-like growth factor 1 receptor on human erythrocytes. J Clin Endocrinol Metabol, 61, 1066-1070 (1985).
25. B. Sivan, P. Lilos and Z. Laron, Effects of insulin-like growth factor-I deficiency and replacement therapy on the hematopoietic system in patients with Laron syndrome (primary growth hormone insensitivity). J Pediatr Endocrinol Metabol, 16, 509-520 (2003).
26. E.R. Christ, M.H. Cunnings, N.B. Westwood, B.M. Sawyer, T.C. Pearson, P.H. Sönksen, and D.J. Russel-Jones, The importance of growth hormone in the regulation of erythropoiesis, red cell mass and plasma volume in adult with growth hormone deficiency. J Clin Endocrinol Metabol, 82, 2985-2990 (1997).
27. E. Long, H.T. Huynh and X. Zhao, Involvement of insulin-like growth factor-1 and its binding proteins in proliferation and differentiation of murine bone marrow-derived macrophage precursors. Endocrine, 9, 185-192 (1998).
28. S. Jeay, G.E. Sonenshein, P.A. Kelly, M.C. Postel-Vinay and E. Baixeras, Growth hormone exerts antiapoptotic and proliferative effects through two different pathways involving nuclear factor-kappaB and phosphatidylinositol 3-kinase. Endocrinology, 142, 147-156 (2001).
29. L. Soon, L. Flechner, J.S. Gutkind, L.H. Wang, R. Baserga, J.H. Pierce and W. Li, Insulin-like growth factor I synergises with interleukin 4 for hematopoietic cell proliferation independent of insulin receptor substrate expression. Mol Cell Biol, 19, 3816-3828 (1999).
30. L.F. Gibson, D. Pitkel and K.S. Landreth, Insulin-like growth factor-I potentiates expansion of interleukin-7 dependent pro-B cells. Blood, 82, 3005-3011 (1993).
31. P. Jardieu, R. Clark, D. Mortensen and K. Dorskind, In vivo administration of insulin-like growth factor-I stimulates primary-B lymphopoiesis and enhances lymphocyte recovery after bone marrow transplantation. J Immunol, 152, 4320-4327 (1994).
32. B. Valentinis, G. Romano, F. Peruzzi, A. Morrione, M. Risco, S. Soddu, B. Cristofanelli, A. Sacchi and R. Baserga, Growth and differentiation signals by the insulin-like growth factor 1 receptor in hemopoietic cells are mediated through different pathways. J Biol Chem, 30, 12423-12430 (1999).
33. B. Lin, Y. Kinoshita, F. Hato and Y. Tsuji, Enhancement of DNA synthetic activity of thymic lymphocytes by the culture supernatant of thymus epithelial cells stimulated by growth hormone. Cell Mol Biol (Noisy-Le-Grand), 43, 351-359 (1999).
34. M.C. Postel-Vinay, V. Mello-Coelho, M.C. Gagnerault and M. Dardenne, Growth hormone stimulates the proliferation of activated mouse T lymphocytes. Endocrinology, 138, 1816-1820 (1997).
35. R. Clark, The somatogenic hormones and insulin-like growth factor-1: stimulators of lymphopoiesis and immune function. Endocrine Rev, 18, 157-179 (1997).
36. P. Sabharwal and S. Varma, Growth hormone synthesized and secreted by human thymocytes acts via insulin-like growth factor I as an autocrine and paracrine growth factor. J Clin Endocrinol Metab, 81, 2663-2669 (1996).
37. K.W. Kelley, S. Brief, H.J. Westly, T. Novakofski, P.J. Bechtel, J. Simon and E.B. Walker, GH3 pituitary adenoma cells can reverse thymic aging in rats. Proc Natl Acad Sci USA, 83, 5663-5667 (1986).
38. K. Binz, P. Joller, P. Froesch, H. Binz, J. Zapf and E.R. Froesch, Repopulation of the atrophied thymus in diabetic rats by insulin-like growth factor I. Proc Natl Acad Sci USA, 87, 3690-3694 (1990).
39. W.E. Beschorner, J. Divic, H. Pulido, X. Yao, P. Kenworthy and G. Bruce, Enhancement of thymic recovery after cyclosporine by recombinant human growth hormone and insulin-like growth factor I. Transplantation, 52, 879-884 (1991).
40. N. Bazzoni, B. Ambrosi, M. Arosio, M. Barbareschi, M. Losa and G. Faglia, Acromegaly and thymic hyperplasia: a case report. J Endocrinol Invest, 11, 931-935 (1990).
41. L.A. Napolitano, J.C. Lo, M.B. Gotway, K. Mulligan, J.D. Barbour, D. Schmidt, R.M. Grant, R.A. Halvorsen, M. Schambelan and J.M. McCune, Increased thymic mass and circulating naïve CD4 T cells in HIV-1-infected adults treated with growth hormone. AIDS, 16, 1103-1110 (2002).
42. E. Montecino-Rodriguez, R. Clark and K. Dorshkind, Effects of insulin-like growth factor administration and bone marrow transplantation on thymopoiesis in aged mice. Endocrinology, 139, 4120-4126 (1998).
43. J.C. Woo, G.A. Dean, R. Clark and P.F. Moore, Investigation of recombinant human insulin-like growth factor type I in thymus regeneration in the acute stage of experimental FIV infection in juvenile cats. AIDS Res Hum Retroviruses, 10, 1377-1388 (1999).
44. A.F. Tarantal, M.K. Hunter and S.E. Garkosky, Direct administration of insulin-like growth factor to fetal rhesus monkeys (Macaca mulatta). Endocrinology, 138, 3349-3358 (1997).
45. S. Jeay, G.E. Sonenshein, M.C. Postel-Vinay and E. Baixeras, Growth Hormone prevents apoptosis through activation of nuclear factor-kB in interleukin-3 dependent Ba/F3 cell line. Mol Endocrinol, 14, 650-661 (2000).
46. E. Baixeras, S. Jeay, P. Kelly and M.C. Postel-Vinay, The proliferative and antiapoptotic actions of growth hormone and insulin-like growth factor-1 are mediated through distinct signaling pathways in the pro-B Ba/F3 cell line. Endocrinology, 142, 2968-2977 (2001).
47. J. Suzuki, Y. Kaziro and H. Koide, Synergistic action of R-Ras and IGF-1 on Bcl-xL expression and caspase inhibition in BaF3 cells: R-Ras and IGF-1 control distinct anti-apoptotic kinase pathways. FEBS Lett, 437, 112-116 (1998).
48. C. Carlo-Stella, M. Di Incola, R. Milani, P. Longoni, M. Milanesi, A. Bifulo, C. Stucchi, A. Gidetti, L. Cleris, F. Formelli, G. Garotta and A.M. Gianni, Age- and irradiation-associated loss of bonne marrow hematopoietic function in mice is reversed by recombinant human growth hormone. Exp Hematol, 32, 171-178 (2004).
49. K. Vanderkerken, K. Asosingh, F. Braet, I. van Riet and B. van Camp, Insulin-like growth factor-1 acts as a chemoattractant factor for 5T2 multiple myeloma cells. Blood, 93, 235-241 (1999).
50. Y.T. Tai, K. Podar, L. Alley, Y.H. Tseng, M. Akiyama, R. Shringarpure, R. Burger, T. Hideshima, D. Chauhan, N. Mitsiades, P. Richardson, N.C. Munshi, C.R. Kahun, C. Mitsiades and K.C. Anderson, Insulin-like growth factor-1 induces adhesion and migration in human multiple myeloma cells via activation of beta1-integrin and phosphatidylinositol 3′-kinase/AKT signaling. Cancer Res, 15, 5850-5858 (2003).
51. Y.W. Qiang, L. Yao, G. Tosato and S. Rudikoff, Insulin-like growth factor I induces migration and invasion of multiple myeloma cells. Blood, 103, 301-308 (2004).
52. D.D. Taub, G. Tsarfaty, A.R. Lloyd, S.K. Durum, D.L. Longo and W.J. Murphy, Growth hormone promotes human T cell adhesion and migration to both human and murine matrix proteins in vitro and directly promotes xenogeneic engraftment. J Clin Invest, 94, 293-300 (1994).
53. V. Mello-Coelho, D.M.S. Villa-Verde, M. Dardenne and W. Savino, Pituitary hormones modulate cell-cell interactions between thymocytes and thymic epithelial cells. J Neuroimmunol, 76, 39-49 (1997).
54. W. Savino, S. Smaniotto, N. Binart, M.C. Postel-Vinay and M. Dardenne, In vivo effects of growth hormone on thymic cells. Ann NY Acad Sci, 992, 179-185 (2003).
55. M.C. Gagnerault, M.C. Postel-Vinay and M. Dardenne, Expression of growth hormone receptors in murine lymphoid cells analyzed by flow cytofluorometry. Endocrinology, 137, 1719-1726 (1996).
56. V. Mello-Coelho, M.C. Gagnerault, J.C. Souberbielle, C.J. Strasburger, W. Savino, M. Dardenne and M.C. Postel-Vinay, Growth hormone and its receptor are expressed in human thymic cells. Endocrinology, 139, 3837-3842 (1998).
57. C.K. Edwards, L.M. Yunger, R.M. Lorence, R. Dantzer and K.W. Kelley, The pituitary gland is required for protection against lethal effects of Salmonella typhimurium. Proc Natl Acd Sci USA, 88, 2274-2277 (1991).
58. T. Inoue, H. Saito, T. Matsuda, K. Fukatsu, I. Han, S. Furukawa, S. Ikeda and T. Muto, Growth hormone and insulin-like growth factor-1 augment bactericidal capacity of human polymorphonuclear neutrophils. Shock, 10, 278-284 (1998).
59. S. Verland and S. Gammeltoft, Functional receptors for insulin-like growth factors I and II in rat thymocytes and mouse thymoma cells. Mol Cell Endocrinol, 67, 207-216 (1989).
60. R. Kooijman, L.E. Scholtens, G.T. Rijkers and B.J. Zegers, Type I insulin-like growth factor receptor expression in different developmental stages of human thymocytes. J Endocrinol, 147, 203-209 (1995).
61. V. Mello-Coelho, D.M.S. Villa-Verde, D.A. Farias-de-Oliveira, J.M. Brito, M. Dardenne and W. Savino, Functional growth hormone-controlled IGF-1/IGF-1 receptor autocrine/paracrine circuit in human and murine thymic epithelial cells. Neuroendocrinology, 75, 139-150 (2002).
62. X. Xu, C. Mardell, C.J. Xian, H. Zola and L.C. Read, Expression of functional IGF-1 receptor on lymphoid cell subsets of rats. Immunology, 85, 394-399 (1995).
63. M. Majka, A. Janowska-Wieczorek, J. Ratajczak, K. Ehrenman, Z. Pietrzkowski, M.A. Kawalka, A.M. Gewirtz, S.G. Emerson and M.Z. Ratajczak, Numerous growth factors, cytokines, and chemokines are secreted by human CD34+ cells, myeloblats, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner. Blood, 15, 3075-3085 (2001).
64. P.S. Hinton, C.A. Peterson, E.M. Dahly and D.M. Ney, IGF-1 alters lymphocyte survival and regeneration in thymus and spleen after dexamethasone treatment. Am J Physiol, 274, R912-20 (1998).
65. O. Kecha, F. Brilot, H. Martens, N. Franchimont, C. Renard, R. Greimers, M.P. Defresne, R. Winkler and V. Geneen, Involvement of insulin-like growth factors in early T cell development: a study using fetal thymic organ cultures. Endocrinology, 141, 1209-1917 (2000).
66. K. Dorskind and N.D. Horseman, The roles of prolactin, growth hormone, insulin-like growth factor-I, and thyroid hormones in lymphocyte development and function: insights from genetic models of hormone and hormone receptor deficiency. Endocrine Rev, 21, 292-312 (2000).
67. E. Montecino-Rodriguez, R.G. Clark, L. Power-Braxton and K. Dorshkind, Primary B cell development is impaired in mice with defects of the pituitary/thyroid axis. J Immunol, 159, 2712-2719 (1997).
68. B.Y. Nguyen, M. Clerici, D.J. Venzon, S. Bauza, W.J. Murphy, D. Longo, M. Baseler, N. Gesundheit, S. Broder, G. Shearer and R. Yarchoan, Pilot study of the immunologic effects of recombinant human growth hormone and insulin-like growth factor in HIV-infected patients. AIDS Infection, 12, 895-904 (1998).
69. O. Alpdogan, S.J. Muriglan, B.J. Kappel, E. Doubrovina, C. Schmaltz, R. Schiro, J.M. Eng, A.S. Greenberg, L.M. Willis, J.A. Rotolo, R.J. O'Reilly and M.R.M. Van Den Brink, Insulin-like growth factor-1 enhances lymphoid and myeloid reconstitution after allogeneic bone marrow transplantation. Transplantation, 75, 1977-1983 (2003).
70. K. Dorshkind and N.D. Horseman, Anterior pituitary hormones, stress, and immune system homeostasis. Bioessays, 23, 288-294 (2001).
71. L.A. Welniak, R. Sun and W.J. Murphy, The role of growth hormone in T-cell development and reconstitution. J Leukocyte Biol, 71, 381-387 (2002).